Loading
A phase 1 trial of SLV-154 run by Solve Therapeutics, now recruiting.
SLV-154 Treatment of Advanced Cancers is a phase 1 interventional study registered as NCT06771219 by Solve Therapeutics, with 250 participants planned, started 2025-05-14. Conditions recorded: Advanced Cancer, Advanced Solid Tumor and Metastatic Cancer. Interventions recorded: SLV-154.
Shares Solve Therapeutics, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Solve Therapeutics, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/